SEARCH

SEARCH BY CITATION

References

  • 1
    Moher D, Jadad A, Nichol G, Penman M, Tugwell T, Walsh S. Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Control Clin Trials 1995;16:6273.
  • 2
    Moher D, Jadad AR, Tugwell P. Assessing the quality of randomized controlled trials: current issues and future directions. Int J Technol Assess Health Care 1996;12:195208.
  • 3
    Alderson P, Green S, Higgins J, editors. Assessment of study quality. In: Cochrane Reviewers’ Handbook 4.2.3 [Updated November 2004]; Section 6.0–6.12. [www.cochrane.org/resources/handbook/hbook.htm]. Accessed 20 December 2004.
  • 4
    Papatsonis D, Flenady V, Cole S, Liley H. Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database Syst Rev 2005; CD004452 [DOI: 10.1002/14651858.CD004452].
  • 5
    King JF, Flenady VJ, Papatsonis DNM, Dekker GA, Carbonne B. Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev 2003; CD002255 [DOI: 10.1002/14651858.CD002255].
  • 6
    King J, Flenady V, Cole S, Thornton S. Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst Rev 2005; CD001992 [DOI: 10.1002/14651858.CD001992].
  • 7
    Anotayanonth S, Subhedar NV, Garner P, Neilson JP, Harigopal S. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev 2004; CD004352 [DOI: 10.1002/14651858.CD004352].
  • 8
    Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev 2002; CD001060 [DOI: 10.1002/14651858.CD001060].
  • 9
    Duckitt K, Thornton S. Nitric oxide donors for the treatment of preterm labour. Cochrane Database Syst Rev 2002; CD002860 [DOI: 10.1002/14651858.CD002860].